- Home
- RQI vs IMTX Comparison
RQI vs IMTX Comparison
Compare RQI & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RQI | IMTX |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RQI | IMTX |
|---|---|---|
| Price | $11.15 | $8.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | ★ 643.3K | 619.0K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 8.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.16 | $7.73 |
| 52 Week High | $13.57 | $12.41 |
Technical Indicators
Market Signals| Indicator | RQI | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 24.41 | 39.86 |
| Support Level | N/A | $8.36 |
| Resistance Level | $13.47 | $10.51 |
| Average True Range (ATR) | 0.19 | 0.34 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 9.31 | 25.42 |
Price Performance
Historical ComparisonAbout RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the fund is high current income through investment in real estate securities. The Fund's secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.